1. Tsuchiya R, Tsunoda T. Tumor size as a predictive factor. Int J Pancreatol. 1990. 7:117.
Article
2. Satake K, Nishiwaki H, Yokomatsu H. Surgical curability and prognosis : standard resection versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet. 1992. 175:259.
4. Yamamoto M, Ohashi O, Saitoh Y. Japan pancreatic cancer resistry : Current status. Pancreas. 1998. 16:238–242.
5. Demeure MJ, Doffek KM, Komorowski RA, Wilson SD. Adenocarcinoma of the pancreas : detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer. 1998. 83:1328–1334.
6. Ariyama J, Suyama M, Satoh K, Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas. 1998. 16:396–401.
Article
7. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Pancreas. 1992. 7:66–86.
Article
8. Lynch HT. Genetics and pancreatic cancer. Arch Surg. 1994. 129:266–268.
Article
9. Lynch HT, Fusaro L, Lynch JF. Familial pancreatic cancer. A family study. Pancreas. 1992. 7:511–511.
10. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology. 1952. 21:54–63.
Article
11. Ekbom A, McLaughlin JK, Karlsson B, Nyren O, Gridley G, Fraumeri JF, et al. Pancreatitis and pancreatic cancer: A population-based study. J Natl Cancer Inst. 1994. 86:625–627.
Article
12. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, DiFrancesco V, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993. 328:1433–1437.
Article
13. McKusick VA. Mendelian inheritance in man. 1990. Baltimore: Johns Hopkins University Press.
14. Satake K, Takeuchi T, Homma T, et al. Ca 19-9 as a screening and diagnostic tool in symptomatic patients : The Japanese experience. Pancreas. 1994. 9:703–706.
Article
15. Matsumoto S, Harada H, Tanaka J, Ochi K, Seno T, Kunichika K, et al. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. Pancreas. 1994. 9:741–747.
Article
16. Bang SM, Chung HW, Park SW, Chung JB, Kang JK, Song SY, et al. The usefulness of 18 FDG-PET scan in determination of treatment response in pancreatic cancer. Gastroenterology. 2003. 124:Suppl 1. A–188.
17. Burris HA 3rd, Moore MJ, Andersen J, Green HR, Rothenberg ML, Van Hoty DD, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer : a randomized trial. J Clin Oncol. 1997. 15:2403–2413.
Article
18. Chung HW, Park JY, Kim SA, Shin Y, Park SW, Song SY, et al. Comparison of concurrent chemoradiation between paclitaxel/furtulon and gemcitabine/furtulon for the locally advanced pancreatic carcinoma. Gastroenterology. 2002. 122:Suppl 1. A–337.